PBM proposal comments due Dec 15
Oct 17, 2026 – Oct 25, 2026
-
CMS proposes MA directory checks and PBM limits
CMS proposed on October 16 that Medicare Advantage plans verify provider directories every 90 days and report public accuracy scores, that PBMs report compensation tied to fair market value of services, and that the generic copay for the lowest-income dual-eligibles drop from $1 to $0 in plan year 2028.
Read this issue → -
PBM rule hits Federal Register, comments due Dec 15
CMS proposed rule CMS-4214-P would limit PBM pay tied to Part D drug use, set Medicare Advantage provider directory duties from contract year 2028, and cut the generic copay to $0 for the poorest dual-eligibles from 2028.
Read this issue → -
CMS proposes flat PBM fees in Part D
CMS proposed on October 16 that Part D PBMs be paid only flat, itemized, fair-market-value fees not tied to drug prices, rebates, formulary placement or volume, implementing Section 6224 of the Consolidated Appropriations Act, 2026.
Read this issue → -
PBM proposal comments due Dec 15
CMS proposed a rule on October 16 implementing sections 6219, 6220 and 6224 of the Consolidated Appropriations Act, 2026, paying Part D PBMs flat fair-market-value fees, with comments due 5 p.m. Eastern on December 15, 2026.
Read this issue →